Artykuły w czasopismach na temat „ETS fusions”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „ETS fusions”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Smith, Jenny L., Rhonda E. Ries, Yi-Cheng Wang, Amanda R. Leonti, Todd A. Alonzo, Alan S. Gamis, Richard Aplenc i in. "ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications". Blood 138, Supplement 1 (5.11.2021): 2356. http://dx.doi.org/10.1182/blood-2021-148894.
Pełny tekst źródłaBarbi de Moura, Michelle, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R. Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar i Steven Canfield. "Erythroblast transformation-specific transcription factor fusions in prostate cancer." Journal of Clinical Oncology 41, nr 6_suppl (20.02.2023): 224. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.224.
Pełny tekst źródłaStaege, Martin S., i Daniela Max. "Genetics and Epigenetics of the TET-ETS Translocation Network". Genetics & Epigenetics 2 (styczeń 2009): GEG.S2815. http://dx.doi.org/10.4137/geg.s2815.
Pełny tekst źródłaWei, Ting, Ji Lu, Tao Ma, Haojie Huang, Jean-Pierre Kocher i Liguo Wang. "Re-Evaluate Fusion Genes in Prostate Cancer". Cancer Informatics 20 (styczeń 2021): 117693512110275. http://dx.doi.org/10.1177/11769351211027592.
Pełny tekst źródłaGasi Tandefelt, Delila, Joost Boormans, Karin Hermans i Jan Trapman. "ETS fusion genes in prostate cancer". Endocrine-Related Cancer 21, nr 3 (20.03.2014): R143—R152. http://dx.doi.org/10.1530/erc-13-0390.
Pełny tekst źródłaAnderson, Nathaniel D., Richard de Borja, Matthew D. Young, Fabio Fuligni, Andrej Rosic, Nicola D. Roberts, Simon Hajjar i in. "Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors". Science 361, nr 6405 (30.08.2018): eaam8419. http://dx.doi.org/10.1126/science.aam8419.
Pełny tekst źródłaButeyn, Nathaniel J., Connor Burke, Eve Gardner, Vincent J. Sartori, Rhonda E. Ries, Todd A. Alonzo, Soheil Meshinchi i Timothy Triche. "Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers". Blood 142, Supplement 1 (28.11.2023): 4298. http://dx.doi.org/10.1182/blood-2023-189474.
Pełny tekst źródłaLawlor, E. R., J. A. Mathers, T. Bainbridge, D. E. Horsman, A. Kawai, J. H. Healey, A. G. Huvos, J. A. Bridge, M. Ladanyi i P. H. Sorensen. "Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis." Journal of Clinical Oncology 16, nr 3 (marzec 1998): 1150–57. http://dx.doi.org/10.1200/jco.1998.16.3.1150.
Pełny tekst źródłaDowning, Nicholas F., Kaitlyn M. Mills i Peter C. Hollenhorst. "Abstract 3033: Oncogenic ETS transcription factors avoid repression by EZH2 and FOXO1 in prostate cancer and Ewing sarcoma". Cancer Research 84, nr 6_Supplement (22.03.2024): 3033. http://dx.doi.org/10.1158/1538-7445.am2024-3033.
Pełny tekst źródłaClark, Jeremy P., i Colin S. Cooper. "ETS gene fusions in prostate cancer". Nature Reviews Urology 6, nr 8 (sierpień 2009): 429–39. http://dx.doi.org/10.1038/nrurol.2009.127.
Pełny tekst źródłaDeneen, Benjamin, Scott M. Welford, Thu Ho, Felicia Hernandez, Irwin Kurland i Christopher T. Denny. "PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins". Molecular and Cellular Biology 23, nr 11 (1.06.2003): 3897–908. http://dx.doi.org/10.1128/mcb.23.11.3897-3908.2003.
Pełny tekst źródłaMani, Ram-Shankar, Scott A. Tomlins, Kaitlin Callahan, Aparna Ghosh, Mukesh K. Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy i Arul M. Chinnaiyan. "Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer". Science 326, nr 5957 (29.10.2009): 1230. http://dx.doi.org/10.1126/science.1178124.
Pełny tekst źródłaHussain, Maha, Stephanie Daignault-Newton, Przemyslaw W. Twardowski, Costantine Albany, Mark N. Stein, Lakshmi P. Kunju, Javed Siddiqui i in. "Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012". Journal of Clinical Oncology 36, nr 10 (1.04.2018): 991–99. http://dx.doi.org/10.1200/jco.2017.75.7310.
Pełny tekst źródłaZhang, Yue. "Article Commentary: ETS-FUSions Networking, Triggering and Beyond". Genetics & Epigenetics 3 (styczeń 2010): GEG.S4166. http://dx.doi.org/10.4137/geg.s4166.
Pełny tekst źródłaFeng, Felix Y., J. Chad Brenner, Maha Hussain i Arul M. Chinnaiyan. "Molecular Pathways: Targeting ETS Gene Fusions in Cancer". Clinical Cancer Research 20, nr 17 (23.06.2014): 4442–48. http://dx.doi.org/10.1158/1078-0432.ccr-13-0275.
Pełny tekst źródłaZou, Ying S., Laura Morsberger, Melanie Hardy, Jen Ghabrial, Victoria Stinnett, Jaclyn B. Murry, Patty Long i in. "Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas". Genes 14, nr 6 (24.05.2023): 1139. http://dx.doi.org/10.3390/genes14061139.
Pełny tekst źródłaYoshimoto, M., A. M. Joshua, S. Chilton-Macneill, J. Bayani, M. Prasad, N. Fleshner, A. Finelli i in. "Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 10029. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10029.
Pełny tekst źródłaHe, Wei, Fukang Sun, Juping Zhao, Dai Jun, Le Xu, Chenghe Wang, Chen Fang i in. "Prevalence and genetic features of TMPRSS2-ERG fusion in Chinese patients with prostate cancer." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e17529-e17529. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e17529.
Pełny tekst źródłaArvand, Afsane, i Christopher T. Denny. "Biology of EWS/ETS fusions in Ewing's family tumors". Oncogene 20, nr 40 (wrzesień 2001): 5747–54. http://dx.doi.org/10.1038/sj.onc.1204598.
Pełny tekst źródłaKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D i Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, nr 9 (26.04.2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Pełny tekst źródłaKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D i Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, nr 9 (26.04.2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Pełny tekst źródłaZhang, Zhusheng, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Qi Liu, Yuhui Shen, Lin Shao, Bing Li, Song-An Chen i Weibin Zhang. "Abstract 4545: Integrative immune-genomic comparison of canonical Ewing sarcoma with Ewing-like mimics identifies potential targets for personalized therapies". Cancer Research 83, nr 7_Supplement (4.04.2023): 4545. http://dx.doi.org/10.1158/1538-7445.am2023-4545.
Pełny tekst źródłaLe Deley, Marie-Cecile, Olivier Delattre, Karl-Ludwig Schaefer, Sue A. Burchill, Gabriele Koehler, Pancras C. W. Hogendoorn, Thomas Lion i in. "Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial". Journal of Clinical Oncology 28, nr 12 (20.04.2010): 1982–88. http://dx.doi.org/10.1200/jco.2009.23.3585.
Pełny tekst źródłaAnderson, Peter Meade, Luisa-Marie Manning, Brian Rubin, Timothy A. Chan, Scott E. Kilpatrick, Rabi Hanna i Zheng Jin Tu. "Nested set information derived from fusion genes in Ewing sarcoma and other cancers." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): e23521-e23521. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e23521.
Pełny tekst źródłaFeng, Felix Yi-Chung, Scott Tomlins, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Robert Benjamin Den i in. "Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes." Journal of Clinical Oncology 33, nr 7_suppl (1.03.2015): 9. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.9.
Pełny tekst źródłaSmit, F. P., M. Salagierski, D. Hessels, S. A. Jannink i J. A. Schalken. "786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS". European Urology Supplements 8, nr 4 (marzec 2009): 317. http://dx.doi.org/10.1016/s1569-9056(09)60774-0.
Pełny tekst źródłaHammer, Liat, Ryan Rebernick, Matthew McFarlane, Thomas Westbrook, Munna Hazime, Tanya Hammoud, Pin-en Chiu i in. "Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer." Journal of Clinical Oncology 41, nr 6_suppl (20.02.2023): 263. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.263.
Pełny tekst źródłaHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank i Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, nr 12 (15.06.1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.
Pełny tekst źródłaHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank i Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, nr 12 (15.06.1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.412k30_4354_4364.
Pełny tekst źródłaYaseen, Nabeel R., Akiko Takeda, Reza Nazari, Helen Shio, Gunter Blobel i Hualin Zhong. "Carrier-Independent Nuclear Import of the Transcription Factor PU.1." Blood 104, nr 11 (16.11.2004): 3561. http://dx.doi.org/10.1182/blood.v104.11.3561.3561.
Pełny tekst źródłaFeng, F. Y., S. Han, C. Brenner, A. Sabolch, D. A. Hamstra, T. S. Lawrence i A. Chinnaiyan. "PARP inhibition reverses radiation resistance conferred by ETS fusions in prostate cancer." Journal of Clinical Oncology 29, nr 15_suppl (20.05.2011): 4545. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4545.
Pełny tekst źródłaTomlins, Scott A., Anders Bjartell, Arul M. Chinnaiyan, Guido Jenster, Robert K. Nam, Mark A. Rubin i Jack A. Schalken. "ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice". European Urology 56, nr 2 (sierpień 2009): 275–86. http://dx.doi.org/10.1016/j.eururo.2009.04.036.
Pełny tekst źródłaDong, Rongfang, Lan Li, Lihua Gong, Mengmeng Tian, Tingting Zhang, Wen Zhang i Yi Ding. "Abstract 2152: Targetable oncogenic fusions and other alterations in bone and soft-tissue tumors assessed by RNA and DNA-based next-generation sequencing in real-world experience". Cancer Research 83, nr 7_Supplement (4.04.2023): 2152. http://dx.doi.org/10.1158/1538-7445.am2023-2152.
Pełny tekst źródłaBilke, Sven, Raphaela Schwentner, Fan Yang, Maximilian Kauer, Gunhild Jug, Robert L. Walker, Sean Davis i in. "Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer". Genome Research 23, nr 11 (12.08.2013): 1797–809. http://dx.doi.org/10.1101/gr.151340.112.
Pełny tekst źródłaTomlins, Scott A., Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon i in. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Nature 448, nr 7153 (sierpień 2007): 595–99. http://dx.doi.org/10.1038/nature06024.
Pełny tekst źródłaDehm, Scott M. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Urologic Oncology: Seminars and Original Investigations 26, nr 6 (listopad 2008): 687–88. http://dx.doi.org/10.1016/j.urolonc.2008.09.003.
Pełny tekst źródłaDong, Jun, Li Xiao, Lu Sheng, Jun Xu i Zhong-Quan Sun. "TMPRSS2:ETS Fusions and Clinicopathologic Characteristics of Prostate Cancer Patients from Eastern China". Asian Pacific Journal of Cancer Prevention 15, nr 7 (1.04.2014): 3099–103. http://dx.doi.org/10.7314/apjcp.2014.15.7.3099.
Pełny tekst źródłaDan, Yuqing, Ruibao Ren, Donghe Li i Ping Liu. "Novel Fusion Gene Aven-NUTM1 Induces Mice Myeloid Leukemia Vulnerable to HDAC Inhibitors". Blood 142, Supplement 1 (28.11.2023): 4123. http://dx.doi.org/10.1182/blood-2023-188034.
Pełny tekst źródłaCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer i Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, nr 5 (1.09.1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.
Pełny tekst źródłaCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer i Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, nr 5 (1.09.1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.417k09_1820_1824.
Pełny tekst źródłaThompson, Andrew D., Michael A. Teitell, Afsane Arvand i Christopher T. Denny. "Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells". Oncogene 18, nr 40 (wrzesień 1999): 5506–13. http://dx.doi.org/10.1038/sj.onc.1202928.
Pełny tekst źródłaBraunreiter, Chi L., Jeffery D. Hancock, Cheryl Coffin, Kenneth M. Boucher i Stephen L. Lessnick. "Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma". Cell Cycle 5, nr 23 (17.11.2006): 2753–59. http://dx.doi.org/10.4161/cc.5.23.3505.
Pełny tekst źródłaPaulo, Paula, João D. Barros-Silva, Franclim R. Ribeiro, João Ramalho-Carvalho, Carmen Jerónimo, Rui Henrique, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe i Manuel R. Teixeira. "FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer". Genes, Chromosomes and Cancer 51, nr 3 (12.11.2011): 240–49. http://dx.doi.org/10.1002/gcc.20948.
Pełny tekst źródłaSeligson, Nathan David, Richard D. Maradiaga, Colin W. Stets, Howard Katzenstein, Sherri Z. Millis, John L. Hays i James Lin Chen. "Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e23536-e23536. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e23536.
Pełny tekst źródłaGUO, Xiao-Qiang, Yao-Ting GUI i Zhi-Ming CAI. "The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer". Hereditas (Beijing) 33, nr 2 (5.05.2011): 117–22. http://dx.doi.org/10.3724/sp.j.1005.2011.00117.
Pełny tekst źródłaPflueger, D., S. Terry, A. Sboner, L. Habegger, R. Esgueva, P. C. Lin, M. A. Svensson i in. "Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing". Genome Research 21, nr 1 (29.10.2010): 56–67. http://dx.doi.org/10.1101/gr.110684.110.
Pełny tekst źródłaMiyagi, Yohei, Takeshi Sasaki, Kiyoshi Fujinami, Jinyu Sano, Yutaka Senga, Takeshi Miura, Yoichi Kameda i in. "ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples". Modern Pathology 23, nr 11 (6.08.2010): 1492–98. http://dx.doi.org/10.1038/modpathol.2010.149.
Pełny tekst źródłaXu, Kemin, Alexandra Budhai, Rugved Pattarkine i Minghao Zhong. "Detecting FLI1 Fusion by Immunohistochemistry (IHC) Stain in Prostatic Adenocarcinoma". American Journal of Clinical Pathology 152, Supplement_1 (11.09.2019): S72—S73. http://dx.doi.org/10.1093/ajcp/aqz113.087.
Pełny tekst źródłaNakagawa, Hidewaki. "Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis". Endocrine-Related Cancer 20, nr 4 (26.04.2013): R171—R181. http://dx.doi.org/10.1530/erc-13-0113.
Pełny tekst źródłaMorris, David S., Scott A. Tomlins, Daniel R. Rhodes, Jianjun Yu, Mark A. Rubin, Anders S. Bjartell i Arul M. Chinnaiyan. "OUTLIER EXPRESSION OF SPINK1 IDENTIFIES AN AGGRESSIVE MOLECULAR SUBTYPE IN PROSTATE CANCERS WITHOUT ETS GENE FUSIONS". Journal of Urology 179, nr 4S (kwiecień 2008): 707. http://dx.doi.org/10.1016/s0022-5347(08)62060-1.
Pełny tekst źródła